NOVARTIS AG (NVSEF)
Clinical trial NCT07550517 updates: 1. start date: 2026-04-01 → 2026-07-01 2. completion date: 2033-04-01 → 2033-07-01 3. primary completion date: 2032-04-01 → 2032-07-01
Clinical trial NCT07550517 updates: 1. start date: 2026-04-01 → 2026-07-01 2. completion date: 2033-04-01 → 2033-07-01 3. primary completion date: 2032-04-01 → 2032-07-01
Clinical trial NCT00201955 updates: 1. primary completion date: not set → 2006-07-01 2. enrollment: 740 → 762 participants 3. enrollment type: not set → ACTUAL 4. masking: DOUBLE → TRIPLE
Clinical trial NCT07614360: enrollment: 120 → 150 participants.
Clinical trial NCT02750358 updates: 1. completion date: 2026-05-01 → 2027-05-01 2. primary completion date: 2026-05-01 → 2027-05-01
Clinical trial NCT06511193 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-20 → 2026-05-05 3. primary completion date: 2026-05-20 → 2026-05-05
Clinical trial NCT07215390 updates: 1. start date: 2025-09-29 → 2025-06-23 2. completion date: 2028-03-23 → 2027-11-01 3. primary completion date: 2027-09-25 → 2027-06-25
Clinical trial NCT05870579 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 48 → 22 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07424222 updates: 1. start date: 2026-06-01 → 2026-07-15 2. completion date: 2029-01-01 → 2029-02-01 3. primary completion date: 2028-06-01 → 2028-07-01
Clinical trial NCT03796884 updates: 1. enrollment: 230 → 150 participants 2. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07660029: status: NOT_YET_RECRUITING → RECRUITING.